COVID-19 – Critical Care Medicines Demand/Supply Management
Posted on:
In order to manage additional demand for medicines in critical care and anaesthesia during the on-going COVID-19 pandemic, the Royal College of Anaesthetists, Association of Anaesthetists, Faculty of Intensive Care Medicine, Intensive Care Society and UK Clinical Pharmacy Association have worked closely with the Chief Pharmaceutical Officer at NHS England to publish the following Drug demand-supply clinical guidance and patient-focussed FAQs:
Anaesthesia: Guidance on potential changes to anaesthetic drug usage and administration during pandemic emergency pressures.
Intensive Care Medicine: Guidance on adaptations to standard UK critical care medication prescribing and administration practices during pandemic emergency pressures.
- Drug demand-supply – patient FAQs